Can Penlac (ciclopirox) be used to treat alopecia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Penlac (Ciclopirox) Is Not Recommended for Treating Alopecia

Penlac (ciclopirox) is not recommended for the treatment of any form of alopecia as there is no evidence supporting its efficacy for this condition. 1

Evidence-Based Treatment Options for Alopecia

For Androgenetic Alopecia:

  • First-line treatments include FDA-approved options:
    • Topical minoxidil (1-5%) for both men and women 2
    • Oral finasteride 1mg daily for men 2, 3
  • Second-line treatments with evidence of efficacy:
    • Oral dutasteride 0.5mg daily (better response than finasteride, especially in frontal area) 3
    • Oral minoxidil at 2.5-5mg daily (not FDA-approved but shown effective in clinical studies) 3
    • Topical finasteride 0.25% daily (less systemic effects than oral) 3

For Alopecia Areata:

  • For limited patchy hair loss:
    • Intralesional corticosteroids are the first-line treatment (Strength of recommendation B, Quality of evidence III) 1, 4
    • Hydrocortisone acetate (25 mg/mL) or triamcinolone acetonide (5-10 mg/mL) injected just beneath the dermis 1
  • For extensive patchy hair loss:
    • Contact immunotherapy (Strength of recommendation B, Quality of evidence II-ii) 1
    • DPCP (diphenylcyclopropenone) is typically used with a protocol starting at 0.001% concentration 1
  • For severe/refractory cases:
    • JAK inhibitors: baricitinib (JAK 1/2) for adults and ritlecitinib (JAK 3/TEC) for ages 12+ are now EMA-approved 5
    • Methotrexate (15-25mg weekly) for refractory cases 4
    • Systemic corticosteroids (limited evidence of efficacy, significant side effects) 1

Adjunctive Therapies

  • Platelet-rich plasma (PRF) has shown promise for androgenetic alopecia, particularly in mild cases 1
    • Protocol typically involves 3-5 sessions at 1-month intervals 1
  • Low-level laser therapy (630-660nm wavelength) can be used daily for 15-30 minutes 3
  • For cosmetic coverage in extensive alopecia:
    • Wigs or hairpieces (acrylic or human hair) 1

Important Clinical Considerations

  • Ciclopirox (Penlac) is an antifungal medication with no established role in treating any form of alopecia 1
  • Spontaneous remission occurs in alopecia areata, so not treating is sometimes the best option 1
  • Treatment response rates decrease with more extensive hair loss, particularly in alopecia totalis/universalis 1
  • Children with alopecia areata may require modified approaches as they often poorly tolerate intralesional corticosteroids 1
  • Combination therapies may be more effective than monotherapy, especially in resistant cases 1, 6

Treatment Algorithm

  1. Identify the type of alopecia (androgenetic vs. areata vs. other)
  2. Assess extent and duration of hair loss
  3. For androgenetic alopecia: Start with minoxidil and/or finasteride (men) or minoxidil alone (women) 2, 3
  4. For limited alopecia areata: Begin with intralesional corticosteroids 1, 4
  5. For extensive alopecia areata: Consider contact immunotherapy or systemic options 1
  6. Monitor response after 3-6 months and adjust treatment accordingly 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

What's New in Therapy for Male Androgenetic Alopecia?

American journal of clinical dermatology, 2023

Guideline

Treatment Options for Facial Alopecia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

European expert consensus statement on the systemic treatment of alopecia areata.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.